- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 7.47M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.39M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.68M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.65M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $5.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $23.26M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $21.05M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $5.17M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $5.86M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.1M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.81M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.88M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.94M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $30.24M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $25.38M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $31.05M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $25.84M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.43 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.45 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.68M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.01M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $28.6K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $60.82K |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.25M |
| Net Income | Q1 2026 · Mar 31, 2025 | $385.17K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.32M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.07M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $17.37K |
| Revenue | Q1 2026 · Mar 31, 2026 | $388.77K |
| Revenue | Q1 2026 · Dec 31, 2025 | $0 |